
|Videos|May 26, 2020
The immunocompromised dermatology patient and COVID-19
Author(s)Jessica Barry
In light of the ongoing pandemic, Vivian Shi, M.D., discusses potential risks dermatologists will want to keep in mind when evaluating patients currently taking immunomodulator or immunosuppressant drugs.
Advertisement
In light of the ongoing pandemic, Vivian Shi, M.D., assistant professor of dermatology at the University of Arizona College of Medicine, Tucson, Ariz., discusses potential risks dermatologists will want to keep in mind when evaluating patients currently taking immunomodulator or immunosuppressant drugs.
References:
Price KN, Frew JW, Hsiao JL, Shi VY. COVID-19 and immunomodulator/immunosuppressant use in dermatology. J Am Acad Dermatol. 2020;82(5):e173-e175.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: The Summer Skin Care "Shutdown"
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
4
Breakout Bulletin: July 13-July 17
5











